Gene Query: STIL

Dataset Description Geneva Score
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 48.63
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 36.62
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 36.5
LncRNA-GAS5 negative regulation of YAP-target genes expression 33.83
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 26.66
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 25.83
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 24.62
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 24.19
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 22.89
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 22.45
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 21.78
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 21.51
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 20.94
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 20.87
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 20.63
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 20.39
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 20.39
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 19.41
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 19.29
DIGIT regulates endoderm differentiation of human embryonic stem cells 19.15
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 18.94
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 18.58
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 18.58
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 18.45
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 18.17
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 18.1
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 17.76
Transcriptomic analyssis following EHMT1/2 inhibition 17.64
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 17.44
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 17.44
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 16.93
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 16.75
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 16.32
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 16.26
Short and Long RNA sequencing of human mature erythrocytes 15.59
Genome-wide transcriptional response to random aneuploidy in human cells 15.33
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 15.18
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 14.94
Transcription control by the ENL YEATS domain in acute leukemia 14.94
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 14.77
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 14.76
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 14.36
RNA-seq analysis to identify the genes regulated by p53-SET interplay 14.09
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 13.67
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 13.63
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 13.63
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 13.51
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 13.46
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 13.33
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 13.29
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 13.21
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 13.19
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 13.19
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 13.15
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 12.64
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 12.43
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 12.43
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 12.26
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 12.17
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 12.17
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 12.14
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 12.14
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 12.07
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 11.96
Landscape of H3K4me3 in human CD19 cells 11.94
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 11.86
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 11.81
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 11.8
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 11.79
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 11.69
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 11.65
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 11.64
Genes significantly down or Up-regulated upon RNF219 knockdown 11.52
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 11.48
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 11.46
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 11.46
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 11.45
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 11.25
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 11.25
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 11.13
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 11.12
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 11.11
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 10.94
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 10.86
Transcriptional profiles of normal human mature B cells 10.85
Widespread intronic polyadenylation diversifies immune cell transcriptomes 10.83
Role for citron kinase in prostate cancer growth 10.77
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 10.76
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 10.76
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 10.7
Genetic-to-epigenetic Therapy for Pancreatic Cancer 10.58
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 10.57
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 10.54
FBXW7 modulates stress response by post-translational modification of HSF1 10.54
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 10.52
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 10.47
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.46
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 10.45
RNAseq analysis of ESRP regulated splicing events in prostate cancer 10.42
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 10.39
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 10.19
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 10.15
Effect of CHKA knockdown on C4-2 cell transcriptome 10.15
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 10.13
Downregulation of DDX5/DDX17 and REST 10.1
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 9.97
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 9.96
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 9.95
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 9.85
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 9.85
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 9.83
RNA-seq analysis of uveal melanoma cells treated with FR900359 9.81
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.8
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.8
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 9.79
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 9.68
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 9.63
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 9.61
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 9.6
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 9.57
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 9.53
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 9.53
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 9.53
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 9.5
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 9.48
TGF-β regulation of miRNA expression in pancreatic cancer 9.39
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 9.34
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 9.28
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 9.25
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 9.22
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 9.17
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 9.17
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 9.13
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.13
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.13
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 9.12
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 9.05
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 9.05
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 9.03
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 9.01
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 8.99
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.92
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 8.92
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 8.92
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 8.91
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 8.91
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 8.89
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 8.81
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 8.8
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 8.77
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 8.77
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.76
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 8.74
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 8.69
Biological effect of chronic mistranslation in mammalian cells 8.63
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 8.57
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  8.56
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 8.56
Retinoic acid suppresses MYB in adenoid cystic carcinoma 8.56
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 8.53
Human embryonic stem cells in E8 and AKIT culture medium 8.47
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 8.47
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 8.46
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 8.45
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 8.43
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 8.43
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 8.33
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.32
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 8.32
Identification of global regulators of T-helper cell lineage specification 8.27
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.27
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 8.25
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 8.25
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 8.2
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 8.17
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 8.15
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 8.15
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 8.13
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 8.13
Spliceosomal disruption of the non-canonical BAF complex in cancer 8.11
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 8.07
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 8.06
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 8.02
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 8.02
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 7.99
Transcriptome analysis of BAP1 knockout and restoration 7.99
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 7.96
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 7.91
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.89
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 7.84
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 7.84
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 7.81
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.8
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 7.8
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 7.78
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 7.77
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.75
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.75
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 7.73
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 7.73
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.73
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.73
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 7.71
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 7.71
Identification of global XBP1s target gene expression in human prostate cancer cells 7.7
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.7
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 7.7
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 7.65
Seletive inhibition of CDK9 in DLBCL cell lines 7.63
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.63
Integrin signaling regulates YAP/TAZ to control skin homeostasis 7.62
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 7.6
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.59
SUV420H2 knockdown in PANC-1 7.58
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 7.57
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 7.57
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 7.52
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 7.52
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.51
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 7.5
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 7.5
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 7.48
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 7.48
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.47
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.47
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 7.45
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 7.41
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.4
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.39
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 7.38
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 7.38
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.36
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 7.34
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.33
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 7.32
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 7.29
Total RNA-seq in ALL-SIL upon JQ1 inhibition 7.28
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 7.21
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.12
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 7.12
UV_24h_GRO-Seq 7.07
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 7.05
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 7.04
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 7.03
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 6.97
Cerebellar differentiation in Ataxia-Telangiectasia 6.95
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 6.94
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.92
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.92
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 6.92
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 6.91
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 6.91
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 6.9
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 6.89
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.87
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 6.86
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.84
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.84
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.83
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 6.8
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 6.8
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 6.77
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 6.77
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 6.74
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 6.73
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 6.71
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 6.71
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 6.7
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 6.69
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.66
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.66
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.6
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.58
Regulation of protein translation during mitosis 6.55
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.54
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 6.54
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 6.52
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.48
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 6.46
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 6.37
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 6.36
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 6.36
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 6.31
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 6.28
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 6.25
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.24
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.24
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 6.19
Effect of from Human Umbilical Vein Endothelial Cells 6.18
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 6.09
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 6.09
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 6.08
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 6.07
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 6.06
Ro60-knockout cells 6.01
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 6.0
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 6.0
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 5.96
Identification of Sin3B regulated genes during quiescence 5.96
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.96
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 5.95
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.92
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 5.88
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 5.83
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 5.83
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 5.76
mRNA expression profile of Lymphocytes 5.75
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 5.72
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 5.7
Overexpression and knockdown experiment for circCSNK1G3 5.69
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.65
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.63
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 5.61
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 5.61
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 5.59
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 5.59
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 5.55
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.49
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.49
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 5.49
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 5.48
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 5.44
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.42
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.4
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 5.38
Transcriptome of U251 cells overexpression complement component 7 5.38
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 5.37
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 5.36
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 5.32
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 5.32
Genome-wide analysis of Dengue virus 2 infected cells 5.31
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 5.26
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 5.25
RNA-seq in transgenic cells 5.25
SLIGRL-induced gene expression changes in NHEK cells 5.21
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.21
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.15
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 5.1
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 5.1
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 5.1
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 5.0
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.0
Transcriptome-wide identification of CELF2 functional targets in T cells 4.99
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.91
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.91
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.75
The Genetic Landscape of Diamond-Blackfan Anemia 4.71
Identification of HOXB13 target genes responsive to BET inhibitors 4.7
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.7
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 4.66
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 4.64
JunB control of keratinocyte-mediated inflammation [RNA-seq] 4.58
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 4.58
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 4.58
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 4.51
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 4.51
6mer seed toxicity in tumour suppressive microRNAs 4.48
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.48
The cohesin release factor WAPL restricts chromatin loop extension. 4.48
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.44
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 4.27
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.27
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.26
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 4.24
DRB/GRO-Seq -/+ UV 4.13
TAF1 is critical for AE driven leukemogenesis 4.1
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 4.1
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.09
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 4.02
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 3.91
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.88
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.88
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 3.73
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.71
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.71
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.7
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.66
A map of gene expression in neutrophil-like cell lines 3.66
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 3.65
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.59
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 3.49
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.45
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.38
Effect of drugs on transcriptomic profiles 3.36
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.34
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.21
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.14
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.09
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.07
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.04
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 3.03
4sU-seq of HFF exposed to salt and heat stress 3.02
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 3.01
Entrectinib Resistance in a Neuroblastoma Xenograft Model 2.97
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.91
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.88
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.88
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.88
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 2.87
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.86
High-resolution comparative analysis of great ape genomes 2.83
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.8
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.8
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.78
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.78
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 2.73
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 2.73
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.72
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.71
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.71
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.71
Gene expression profile in breast cancer cells 2.71
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.71
Transcriptome sequencing of K-562 cells 2.7
K562 polyA RNA-Seq 2.63
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.61
Bone marrow derived human B cells [normal proB] 2.57
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.55
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.52
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.49
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.45
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.45
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 2.39
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 2.36
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.34
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.28
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 2.21
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 2.08
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 2.08
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.99
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.99
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.94
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.93
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.92
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.89
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.88
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.85
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.79
Transcriptome-wide response to synthetic chromatin protein PcTF 1.78
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.75
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 1.73
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 1.73
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.7
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.68
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.62
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.62
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.59
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.54
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.5
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.5
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.45
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.38
RNA-seq analysis of differentiating human erythroblasts 1.32
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 1.28
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.27
Modulation of nonsense-mediated decay by rapamycin 1.27
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.26
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.26
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 1.25
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 1.25
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 1.17
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 1.17
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.16
RNA-Seq of PRMT1 overexpression ECA109 cells 1.15
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.14
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.13
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.04
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.93
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.89
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.89
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.89
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.84
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.78
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.73
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.64
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.64
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.64
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.64
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.64
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.55
Impact on erythroid progenitor type on erythroid differntiation 0.55
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.54
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.53
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.51
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.5
Gene expression changes due to PARP knockdown in human cells 0.48
SNHG5 siRNA knock down in HCT116 cells 0.47
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.45
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.41
6mer seed toxicity in viral microRNAs 0.38
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  0.35
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.27
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.27
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.26
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.24
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.21
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.19
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.14
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 0.12
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation